Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates (Q29620051)
scientific article (publication date: July 2010)
Language:
(P31) (Q13442814)
(P304) 3167-75
(P407) (Q1860)
(P433) 19
(P478) 28
(P577) Thursday, July 1, 2010
(P921) (Q725307)
(P1433) (Q400292)
(P1476) "Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates" (language: en)
(P2093) Brahmer JR
Drake CG
Wollner I
Powderly JD
Picus J
Sharfman WH
Stankevich E
Pons A
Salay TM
McMiller TL
Gilson MM
Wang C
Selby M
Taube JM
Anders R
Chen L
Korman AJ
Pardoll DM
Lowy I
Topalian SL
(P2860) (Q28131650)
(Q24685406)
(Q28243975)
(Q24535835)
(Q28131654)
(Q28201627)
(Q28144319)
(Q28284177)
(Q34592058)
(Q34578170)
(Q34575119)
(Q36490747)
(Q36439488)
(Q34657638)
(Q40626031)
(Q46362046)
(Q51894674)
(Q46632481)
other details
description scientific article (publication date: July 2010)

External Links